-
公开(公告)号：US20220007686A1
公开(公告)日：2022-01-13
申请号：US17289576
申请日：2019-10-31
发明人： Elka TOUITOU , Hiba NATSHEH
摘要： Cannabinoids-containing aqueous beverage comprising cannabinoids and phospholipids.
-
公开(公告)号：US20220008354A1
公开(公告)日：2022-01-13
申请号：US17289932
申请日：2019-10-31
发明人： Elka TOUITOU , Hiba NATSHEH
IPC分类号： A61K31/05 , A61K9/00 , A61K47/24 , A61K9/48 , A61K31/352
摘要： Essentially water-free liquid composition for oral administration, comprising: from 25% to 75% by weight of one or more cannabinoid (s); and from 25% to 59% by weight one or more phospholipid (s); and optionally one or more antioxidants (s).
-
公开(公告)号：US20190054176A1
公开(公告)日：2019-02-21
申请号：US15781639
申请日：2016-12-06
发明人： Elka TOUITOU
IPC分类号： A61K47/24 , A61K31/05 , A61K31/352 , A61K9/00 , A61P29/02
摘要： Provided is a composition for oral administration which includes a lipophilic active substance and a phospholipid, providing a prolonged therapeutic effect.
-
公开(公告)号：US20170224629A1
公开(公告)日：2017-08-10
申请号：US15413987
申请日：2017-01-24
发明人： Elka TOUITOU
IPC分类号： A61K9/70 , A61K47/24 , A61K47/14 , A61K47/10 , A61K47/38 , A61K31/167 , A61K31/5375 , A61K31/4418 , A61K31/4164 , A61K31/513 , A61K31/575 , A61K31/4174 , A61K31/568 , A61K31/58 , A61K31/433 , A61K31/4406 , A61K38/12 , A61K31/235 , A61K31/565 , A61K31/192 , A61K31/137 , A61K9/00
CPC分类号： A61K9/7015 , A61K9/0014 , A61K9/127 , A61K9/70 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/235 , A61K31/4164 , A61K31/4174 , A61K31/433 , A61K31/4406 , A61K31/4418 , A61K31/513 , A61K31/5375 , A61K31/565 , A61K31/568 , A61K31/575 , A61K31/58 , A61K38/12 , A61K47/10 , A61K47/14 , A61K47/24 , A61K47/38
摘要： Novel topical compositions for the treatment of nail and skin afflictions comprising at least one active agent, at least one volatile solvent, at least one film-forming ingredient and at least one phospholipid, processes for their preparation and methods of treatment of nail and skin afflictions. Following application of the compositions and evaporation of volatile solvents, the composition produces a film, which has web-like structures containing the active agent(s).
-
5.发明申请公开(公告)号：US20220370350A1
公开(公告)日：2022-11-24
申请号：US17836617
申请日：2022-06-09
发明人： Elka TOUITOU , Hiba NATSHEH
IPC分类号： A61K9/107 , A61P25/16 , A61K38/095 , A61K9/00 , A61K31/047 , A61K31/05 , A61K31/135 , A61K31/165 , A61K31/192 , A61K31/4196 , A61K31/426 , A61K31/485 , A61K31/551 , A61K38/12 , A61K38/18 , A61K38/28 , A61K47/02 , A61K47/10 , A61K47/24
摘要： The invention relates to a nasally administrable composition comprising at least one active substance in magnesium-containing vesicular carrier, said carrier comprising glycol, phospholipids, water and at least one magnesium source. Methods for nasal administration of the composition, for example, for pain relief, are also provided.
-
公开(公告)号：US20210369799A1
公开(公告)日：2021-12-02
申请号：US17290908
申请日：2019-10-31
发明人： Elka TOUITOU , Hiba NATSHEH
摘要： A nasal composition comprising one or more vegetable oils that possess medicinal properties for the treatment or improvement of brain/central nervous system conditions and diseases; phospholipids and optionally glycol, the composition being cannabinoids-free.
-
公开(公告)号：US20200345656A1
公开(公告)日：2020-11-05
申请号：US16767799
申请日：2018-11-04
发明人： Elka TOUITOU , Hiba NATSHEH
摘要： A composition for administration into the nasal cavity, the rectal cavity and the vaginal cavity, wherein the composition is an essentially non-aqueous composition comprising: not less than 25% by weight of one or more cannabinoid(s); from 25% to 55% by weight one or more phospholipid(s); and optionally one or more antioxidant(s).
-
8.发明申请公开(公告)号：US20200268662A1
公开(公告)日：2020-08-27
申请号：US16814163
申请日：2020-03-10
发明人： Elka TOUITOU , Hiba NATSHEH
IPC分类号： A61K9/107 , A61K38/28 , A61K9/00 , A61K47/24 , A61K47/10 , A61K47/02 , A61K38/18 , A61K38/095 , A61K31/135 , A61K31/4196 , A61K31/047 , A61K31/05 , A61K31/551 , A61K31/485 , A61K31/192 , A61K38/12 , A61K31/165 , A61K31/426 , A61P25/16
摘要： The invention relates to a nasally administrable composition comprising at least one active substance in magnesium-containing vesicular carrier, said carrier comprising glycol, phospholipids, water and at least one magnesium source. Methods for nasal administration of the composition, for example, for pain relief, are also provided.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.041 秒)
